g5oqjtft | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/g5oqjtft_hasAnnotation_C0939237>
?:creator	<https://research.tib.eu/covid-19/entity/Simon%2C_Nicolas%3B_Alvarez%2C_Jean_Claude>
?:doi	10.1007/s00228-020-03056-y
?:doi	<https://research.tib.eu/covid-19/entity/10.1007/s00228-020-03056-y>
?:journal	Eur_J_Clin_Pharmacol
?:license	no-cc
?:pdf_json_files	document_parses/pdf_json/e54c99fc4f801c914c408bd4f23bebc7e66b413c.json
?:pmc_json_files	document_parses/pmc_json/PMC7690333.xml.json
?:pmcid	<https://research.tib.eu/covid-19/entity/PMC7690333>
?:pmid	<https://research.tib.eu/covid-19/entity/33244631.0>
?:pmid	33244631.0
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
?:sha_id	<https://research.tib.eu/covid-19/entity/e54c99fc4f801c914c408bd4f23bebc7e66b413c>
?:source	Medline; PMC
?:title	Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-11-26

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/g5oqjtft>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/g5oqjtft>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all